Genus plc

Equities

GNS

GB0002074580

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:01 2024-04-26 am EDT			5-day change	1st Jan Change
1,736 ^GBX	+1.88%		+1.05%	-20.00%

Apr. 17	Gigantic marine reptile's fossils found by British girl and father	RE
Mar. 08	Genus Power Infrastructures Forms New Subsidiary	MT

Genus plc completed the acquisition of a 39% stake in Xelect Ltd for £2.4 million.

June 29, 2021

Genus plc acquired 39% stake in Xelect Ltd for £2.4 million in March, 2021. The Corporate Finance team from independent UK law firm Burges Salmon has advised world leading animal genetics company, Genus plc, on its partial acquisition of Xelect Limited. Genus plc completed the acquisition of a 39% stake in Xelect Ltd in March, 2021.

Latest news about Genus plc

Gigantic marine reptile's fossils found by British girl and father	Apr. 17	RE
Genus Power Infrastructures Forms New Subsidiary	Mar. 08	MT
Genus Power Forms Three Wholly-Owned Subsidiaries; Shares Up 3%	Mar. 07	MT
The calm after the storm	Feb. 28
ANALYST RECOMMENDATIONS : Amex, Apollo Global Management, Crowdstrike, Workday, Abrdn...	Feb. 28
NobleOak Life Shares Add 7% Despite 55% Plunge in Fiscal H1 Profit	Feb. 27	MT
Genus touts programme to boost investment returns as profit declines	Feb. 22	AN
Transcript : Genus plc, H1 2024 Earnings Call, Feb 22, 2024	Feb. 22
Genus Posts Higher Fiscal H1 Attributable Profit; Revenue Down	Feb. 22	MT
Genus plc Proposes Interim Dividend	Feb. 22	CI
Genus plc Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22	CI
Transcript : Genus plc, H1 2024 Pre Recorded Earnings Call, Feb 22, 2024	Feb. 21
Explainer-When the double brood of cicadas will come out - and what to expect	Feb. 19	RE
Stocks in green despite UK hit by recession	Feb. 15	AN
ANALYST RECOMMENDATIONS : Coinbase, Comcast, Eli Lilly, Nvidia, Uber...	Feb. 15
Genus shares plunge as expects adjusted profit and revenue decline	Feb. 15	AN
Stocks rise as poor UK data puts eyes on BoE	Feb. 15	AN
Genus Forecasts Lower Adjusted Pretax Profit for FY24	Feb. 15	MT
Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024	Feb. 15	CI
US Futures, European Stocks Down as Market Dials Back Rate-Cut Bets	Jan. 17	DJ
Genus Paper HR Chief Steps Down	Jan. 16	MT
Scientists conclude New Mexico fossil is new Tyrannosaurus species	Jan. 11	RE
Kepler Cheuvreux Resumes Genus Coverage at Buy	Dec. 20	MT
UBS cuts DS Smith; Kepler likes Genus	Dec. 20	AN
INDEX-MONITOR: TAG Immobilien to be included in Stoxx Europe 600	Dec. 17	DP

Chart Genus plc

Duration

Period

More charts

Company Profile

Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.

Sector

Biotechnology & Medical Research

Calendar

2024-04-29 - HSBC UK Corporate & Investor Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Genus plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.36 GBP

Average target price

29.62 GBP

Spread / Average Target

+70.59%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENUS PLC	-20.00%	1.42B
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research